Allez à nos transactions
Soins de la Santé

InNeuroCo has been acquired by Integer

The owners of InNeuroCo has sold the company to Integer (NYSE:ITGR).

Founded in 2014 and headquartered in Pembroke Pines, Florida, InNeuroCo is a leading founder-owned designer and contract manufacturer of ultra-precise, highly engineered neurovascular catheters. InNeuroCo’s primary products are single-use catheters principally used in interventional neurovascular procedures for the treatment of ischemic strokes and aneurysms. Offering turnkey product design and development, supported by comprehensive domestic manufacturing capabilities, InNeuroCo serves as a mission-critical supply partner to the world’s preeminent medical device OEMs.

With approximately US$1.4 billion in annual revenue, Integer is one of the largest medical devices outsource manufacturers in the world, serving the cardiac, vascular, rhythm management and neuromodulation markets.

Oaklins TM Capital in the US served as the exclusive financial advisor to InNeuroCo in its sale to Integer (NYSE:ITGR).

Parties prenantes
«InNeuroCo’s founders have enjoyed a long-standing history of success with the Oaklins TM healthcare team. When we began contemplating a transaction for InNeuroCo, it was the obvious choice to serve as our advisor. Throughout this transaction, their knowledge of the neurovascular sector, valuable strategic insights and demonstrated expertise in contract medical manufacturing were critical to engineering a successful outcome for InNeuroCo. We appreciate the team’s tireless dedication and thoughtful approach.»

Marc Litzenberg

President and CEO, InNeuroCo

Contacter l'équipe de la transaction

James McLaren

Directeur général
New York, États-Unis
Oaklins TM Capital

Michael S. Goldman

Directeur général
New York, États-Unis
Oaklins TM Capital

John Dean

Directeur associé
Atlanta, États-Unis
Oaklins TM Capital

Bradley S. Goldstein

Directeur associé
Atlanta, États-Unis
Oaklins TM Capital

Ariel Fieldman

Analyste senior
New York, États-Unis
Oaklins TM Capital

Matthew Halbig

Analyste
Atlanta, États-Unis
Oaklins TM Capital

Transactions connexes

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Soins de la Santé

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

En apprendre plus
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Soins de la Santé

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

En apprendre plus
HD Clinical Ltd. has been acquired by NEXUS AG
Soins de la Santé | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

En apprendre plus